Most people have never heard of Drug Resistant Shigella. And honestly, that’s understandable — until recently, it was considered a relatively manageable infection. A few days of diarrhea, maybe a fever, some stomach cramps, and then it passes. For most healthy adults, the body handles it on its own. For those who needed antibiotics, there were always options. That was the story for decades.
But that story is changing — fast. And nowhere is that change more visible, or more alarming, than in California.
Health officials across the state are now sounding the alarm about a troubling surge in extensively drug-resistant Shigella, commonly abbreviated as XDR Shigella. This isn’t your standard stomach bug anymore. It’s a version of a bacteria that has evolved to shrug off every major antibiotic doctors have in their toolkit. And it’s spreading — through communities, through close contact, and through some of California’s most vulnerable populations.
What Is Shigella and Why Should Californians Care?
Shigella is a type of bacteria that causes an intestinal infection called shigellosis. If you’ve ever had traveler’s diarrhea on a trip abroad, there’s a decent chance Shigella was involved. The infection spreads through what doctors call the fecal-oral route — meaning it typically gets from one person to another via contaminated food, water, or surfaces, or through direct person-to-person contact.
The symptoms aren’t subtle. Diarrhea (often bloody), stomach cramps, nausea, vomiting, and fever are the hallmarks of the illness. For most people, it resolves within a week without any treatment at all. But for people with weakened immune systems, young children, elderly individuals, or those already dealing with other health issues, it can get serious fast.
California typically sees roughly 2,500 cases of Shigella infections every year, according to the California Department of Public Health (CDPH). That’s already a significant number. But the real story isn’t just the total case count — it’s about the increasingly frightening proportion of those cases that are now drug-resistant.
The Rise of XDR Shigella: From Zero to a Growing Threat
Here’s the number that should make you stop and think: In 2011, the Centers for Disease Control and Prevention (CDC) tracked essentially zero cases of extensively drug-resistant Shigella in the United States. By 2023, that figure had climbed to 8.5% of all Shigella isolates analyzed through national surveillance.
That trajectory — from nothing to nearly one in ten cases in just over a decade — represents a dramatic and worrying shift in how this pathogen behaves.
The CDC defines XDR Drug Resistant Shigella as strains that are resistant to all five of the antibiotics most commonly used to treat bacterial infections of this kind: ampicillin, azithromycin, ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole. These aren’t obscure medications. They’re the workhorses of antibiotic treatment, used for decades across a wide range of bacterial infections. When a bacteria becomes resistant to all five of them simultaneously, doctors are essentially left with very few good options.
A comprehensive study published in the CDC’s Morbidity and Mortality Weekly Report (MMWR) in April 2025 analyzed nearly 17,000 Shigella isolates collected between January 2011 and October 2023. The findings painted a sobering picture: XDR cases went from 0% in 2011 to 8.5% by 2023, the majority of XDR cases occurred in adult men rather than the young children who were historically most affected, and approximately one-third of patients with XDR shigellosis required hospitalization.
That hospitalization rate is striking. We’re not talking about a minor inconvenience anymore. We’re talking about a bacterial infection that, in its drug-resistant form, is landing a significant chunk of patients in hospital beds.
California’s Specific Surge: The Numbers Tell a Grim Story
While the national numbers are alarming on their own, California’s situation has its own distinct and concerning flavor.
The California Department of Public Health (CDPH) has been closely tracking a sharp rise in XDR Shigella cases that really accelerated in 2024. In the first five months of 2024 alone, 12% of all Drug Resistant Shigella isolates sequenced in the state were identified as the XDR type — up from 6.8% in all of 2023. That’s nearly a 78% increase in the proportion of drug-resistant strains in just a matter of months.
Los Angeles County has been particularly hard hit. In 2025, Los Angeles County health officials reported 68 confirmed XDR shigellosis cases in 2024, up from 45 in 2023 and just five cases back in 2021. The first XDR Shigella case in LA County was reported back in 2017, which means it took a while to gain traction — but once it did, the numbers accelerated rapidly.
The picture in younger men is even more striking. Among males aged 25 to 34 — the group with the highest overall rates of shigellosis in California — a full 21% of sequenced isolates were identified as XDR in the first five months of 2024. That means more than one in five infections in that demographic was the drug-resistant type.
As of June 2025, the Los Angeles County Department of Public Health issued a specific health advisory noting that XDR Shigella cases were continuing to increase, particularly among men who have sex with men and people living with HIV, and urging healthcare providers to exercise extra vigilance especially around the start of Pride month events.
Who Is Most at Risk? Understanding the High-Risk Populations
One of the more unusual aspects of this XDR Drug Resistant Shigella surge is who it’s hitting hardest. Traditionally, Shigella outbreaks in the United States primarily affected young children — think daycare centers, kindergartens, places where little kids interact closely and handwashing is inconsistent. That pattern has shifted significantly.
Today, the XDR strain is disproportionately showing up in several specific adult populations:
Men Who Have Sex with Men (MSM)
This is the most statistically prominent group in the current outbreak data. Among adult male XDR patients in California with available demographic information, 75% self-identified as men who have sex with men. This likely reflects the transmission dynamics of the bacteria — Shigella can spread through sexual contact, and in communities with higher rates of certain sexual practices, the bacteria has a more direct route between individuals.
It’s important to state clearly that this is an epidemiological pattern, not a moral judgment. Public health data tracks where infections are spreading so that targeted interventions can be deployed. The goal is always to protect these communities, not stigmatize them.
People Experiencing Homelessness
Drug Resistant Shigella thrives in environments where access to clean water, proper sanitation, and handwashing facilities is limited. For people living in encampments, shelters, or on the streets of California’s cities, those conditions are often the daily reality.
Multiple California counties have seen concentrated Shigella outbreaks in homeless populations. In Santa Clara County (San Jose area), a 2024 outbreak saw nine confirmed cases among individuals experiencing homelessness, with six of those requiring hospitalization. Public health workers discovered that several cases were connected to people using the Guadalupe River for bathing and toileting, which contributed to further spread.
In Alameda County, whole-genome sequencing of Shigella isolates from a related outbreak revealed highly similar bacterial sequences across multiple cases, suggesting a clear epidemiological link between individuals experiencing homelessness at different facilities.
Santa Cruz County tackled a Drug Resistant Shigella outbreak primarily among its homeless population in early 2024 as well, requiring collaboration between health centers, emergency preparedness teams, and community organizations to distribute sanitation resources to high-risk areas.
People Living with HIV
Among people who disclosed their HIV status in the national XDR Shigella data, nearly half were living with HIV. This makes biological sense — HIV affects the immune system’s ability to fight off infections, and Shigella in its drug-resistant form is both harder to treat and more likely to cause serious complications in immunocompromised individuals.
International Travelers
Earlier in the history of drug-resistant Shigella in the US, international travel was a major driver — people picked up resistant strains abroad and brought them home. That pattern has shifted. Among patients who provided travel histories in the most recent national data, more than 80% reported they had not left the country recently. This means the drug-resistant strain is now circulating domestically, not just being imported. That’s a significant and concerning development.
Why Treating XDR Shigella Is So Difficult
Here’s where the situation gets genuinely complicated from a medical standpoint. When a patient comes in with a regular Shigella infection, doctors have a clear playbook: pick the appropriate antibiotic based on susceptibility, prescribe it, and the illness typically resolves.
With XDR Drug Resistant Shigella, that playbook essentially doesn’t exist.
The CDC has acknowledged that it currently has no official recommendations for optimal antimicrobial treatment for XDR Shigella, because there simply aren’t adequate data from clinical studies to guide those recommendations. The bacteria is resistant to all five commonly used antibiotics. Some alternative drugs have been discussed — medications like pivmecillinam, fosfomycin, and oral carbapenems — but as of 2025, none of these have been approved by the FDA specifically for the treatment of shigellosis.
That means doctors treating XDR Drug Resistant Shigella patients are essentially working without a net. They may have to use IV antibiotics, consult with infectious disease specialists, and tailor treatment to whatever limited susceptibility testing data is available. For patients who are severely ill or immunocompromised, broader-spectrum IV antibiotics like piperacillin-tazobactam or carbapenems may be the most viable options, but these come with their own risks and are typically reserved for hospital settings.
For mild cases in otherwise healthy individuals, the guidance is actually to hold off on antibiotics entirely — not because treatment isn’t needed, but because using antibiotics that won’t work could make things worse, and mild XDR infections do often resolve on their own within a week.
The problem is that this approach requires knowing you have XDR Drug Resistant Shigella in the first place, which requires laboratory testing — specifically, culture and antimicrobial susceptibility testing (AST). Many patients with diarrheal illness don’t get that level of workup. The CDPH has been urging California clinical laboratories to increase AST testing on all available Shigella isolates precisely because of this gap.
There’s also a broader public health concern about antibiotic resistance genes. XDR Drug Resistant Shigella strains can actually transfer their antibiotic resistance genes to other types of gut bacteria. This means that in theory, the resistance mechanisms powering XDR Shigella could spread beyond just this one pathogen, potentially making other bacterial infections harder to treat as well.
A Genomic Investigation: Tracing the Outbreak’s Origins
Science has given us some powerful new tools to understand exactly how these outbreaks spread — and researchers have been putting those tools to use in California.
A study published in May 2025 in the CDC’s Emerging Infectious Diseases journal described a multidrug-resistant Drug Resistant Shigella sonnei outbreak in Alameda County, California, that occurred in 2023 and 2024. Using whole-genome sequencing and phylodynamic modeling — techniques that analyze the genetic code of individual bacteria to trace how closely related they are — researchers were able to demonstrate that the outbreak isolates were highly similar to one another, confirming an epidemiological link between cases that otherwise might have seemed unrelated.
The genotype involved (called 3.7.26) had reference sequences from the United Kingdom (2013) and France (2014), suggesting an international origin for the lineage, even though the current transmission appears to be occurring domestically. All patients in this particular outbreak recovered, which is somewhat reassuring — but the bigger takeaway is how sophisticated our tracking capabilities have become, and how important that tracking is when dealing with rapidly evolving drug-resistant pathogens.
Separately, a paper published in the American Journal of Infection Control in late 2024 described three cases of XDR Drug Resistant Shigella sonnei in men who have sex with men in Los Angeles, all presenting within a three-month period. Whole-genome sequencing confirmed the cases were related, highlighting how quickly this strain can move through interconnected social networks.
California’s Public Health Response: What Officials Are Doing
To their credit, California health officials haven’t been sitting on their hands. The response has been multi-pronged, though critics might argue it needs to scale up further given the pace of spread.
The California Department of Public Health has issued multiple health alerts and advisories to healthcare providers across the state. These advisories urge clinicians to consider XDR Drug Resistant Shigella in any patient presenting with acute diarrhea, particularly those in higher-risk groups. The CDPH has also asked laboratories to conduct complete antibiotic susceptibility testing on all available Drug Resistant Shigella isolates and report results quickly to local health authorities.
Local health departments have been stepping up their community outreach. In Los Angeles County, in anticipation of Pride events in June 2025 — which historically see increased gatherings in the MSM community — the health department issued a specific advisory asking providers to be extra vigilant, test appropriately, and hold off on empiric antibiotics for mild cases unless absolutely necessary.
In Santa Clara County, the public health response to the 2024 encampment outbreak included direct outreach to homeless populations along the Guadalupe River, installation of handwashing stations, provision of clean water, and coordination with city and county government to identify exposure sites and connect sick individuals with care.
Statewide, the CDPH has been using PulseNet — the CDC’s national molecular surveillance network for enteric pathogens — along with whole-genome sequencing conducted at several California public health laboratories (including labs in Los Angeles County, Orange County, and Santa Clara County) to track XDR isolates in near real-time.
California law (Title 17, Section 2505 of the California Code of Regulations) already requires that clinical laboratories attempt to obtain reflex cultures when Drug Resistant Shigella is identified by culture-independent diagnostic testing, like PCR. But compliance and capacity remain challenges.
The Global Context: California Is Part of a Larger Problem
It’s worth stepping back and putting California’s situation in its broader global context, because this isn’t happening in isolation.
XDR Drug Resistant Shigella outbreaks have been reported in recent years across Europe, the United Kingdom, Canada, and multiple US states. These outbreaks have predominantly occurred among MSM and homeless populations — the same groups seeing elevated rates in California. This international pattern suggests that the drug-resistant strain has been circulating globally and finding its way into vulnerable networks wherever conditions allow.
The World Health Organization has flagged antimicrobial resistance broadly as one of the greatest threats to global health, estimating that over a million people die each year from drug-resistant bacterial infections. XDRDrug Resistant Shigella is one more data point in that larger, deeply concerning story.
What makes the current moment particularly urgent is that drug-resistant Shigella has crossed what epidemiologists call the “endemic threshold” in parts of the United States — meaning it’s no longer a rare imported curiosity but a regular part of the domestic disease landscape. That’s a qualitatively different and more serious situation.
What You Can Do: Prevention Is Still the Best Medicine
Here’s the honest reality: with no FDA-approved oral antibiotic available to treat XDR shigellosis, prevention is not just the best strategy — for now, it’s effectively the primary strategy.
The good news is that the transmission routes of Drug Resistant Shigella are relatively well-understood, and the preventive measures, while unsexy, genuinely work.
Handwashing, Handwashing, Handwashing
This sounds almost embarrassingly basic, but it cannot be overstated. Drug Resistant Shigella spreads through fecal-oral transmission. Thorough handwashing with soap and water for at least 20 seconds after using the toilet, before eating, before preparing food, and after changing diapers or caring for someone who is ill dramatically reduces transmission risk. This is especially important after any activity that could potentially involve contact with fecal material.
Safe Sexual Practices
For the MSM community and others where sexual transmission is a documented route for this pathogen, harm reduction is key. Using condoms and dental dams consistently, washing thoroughly before and after sexual activity, and being aware of symptoms in yourself and partners can reduce transmission. If you experience symptoms — particularly diarrhea, especially bloody diarrhea — avoid sexual contact until you’ve been evaluated.
Food and Water Safety
Avoid eating raw or undercooked food from uncertain sources. Be particularly cautious with produce that may have been washed with contaminated water. If you’re traveling, stick to bottled water and cooked foods from reputable sources.
Know the Symptoms, Seek Testing Early
If you’re in a higher-risk group and develop diarrhea — especially bloody diarrhea — fever, or severe stomach cramps, seek medical attention rather than waiting it out. Mention your risk factors to your provider. Early culture and AST testing can make a significant difference in appropriate management.
Avoid Recreational Water Near Contaminated Areas
As the Santa Clara County outbreak made clear, river water near encampments where infected individuals may be using it for bathing and toileting can become a transmission vector. Avoid contact with and definitely avoid swallowing recreational water in areas flagged by public health authorities.
For Healthcare Providers
The CDPH asks that all clinicians who suspect shigellosis obtain stool cultures and full antimicrobial susceptibility testing rather than relying solely on PCR-based diagnostic tests. Susceptibility data is critical for guiding treatment decisions and cannot be obtained from culture-independent tests alone. All confirmed cases must be reported to local health departments, including demographic and risk factor information where available.
The Road Ahead: What Needs to Change
The drug-resistant Drug Resistant Shigella situation in California highlights several uncomfortable truths about how our healthcare and public health systems are — and aren’t — prepared for the era of antimicrobial resistance.
First, we need faster and more widely accessible susceptibility testing. The gap between a clinical PCR test that says “Drug Resistant Shigella positive” and an actual culture plus AST that tells you which antibiotics will work is a significant problem. Many clinical labs don’t have the resources or capacity to consistently perform the latter, which means doctors are often flying blind.
Second, the FDA approval process for alternative treatments needs to keep pace with the public health threat. Drugs like pivmecillinam, fosfomycin, and oral carbapenems may have genuine utility against XDR Drug Resistant Shigella, but as of now, none are approved for this indication in the United States. Clinical trials and expedited review processes need to happen before we’re facing an even larger crisis.
Third, community-level interventions for homeless populations need to be better funded and more systematically deployed. Access to clean water, sanitation, and handwashing facilities isn’t a luxury — it’s basic infrastructure that prevents disease outbreaks. California’s ongoing challenges with homelessness create persistent conditions in which pathogens like Drug Resistant Shigella can spread far more easily than they should.
Finally, public awareness needs to catch up to the science. Most Californians have never heard of XDR Shigella. Given that the state sees roughly 2,500 Drug Resistant Shigella cases per year and a rapidly growing fraction are now the drug-resistant kind, that information gap is a real public health problem.
Conclusion: Take This Seriously — But Don’t Panic
Drug-resistant Shigella is a genuine and growing public health threat in California. The data are clear, the trends are moving in the wrong direction, and the lack of approved treatment options creates a medical situation that demands attention from policymakers, healthcare providers, and the public alike.
At the same time, this is not a reason for panic. For most healthy people, even XDR Drug Resistant Shigella infection will resolve on its own within a week. The primary concerns are for immunocompromised individuals, people with HIV, those experiencing homelessness, and communities where transmission chains are difficult to interrupt. Targeted prevention, early testing, and careful use of antibiotics can make a real difference.
What’s needed now is sustained attention — from California’s public health infrastructure, from its clinical community, and from the public. The story of drug-resistant Shigella in California is still being written. The ending depends in large part on how seriously we take the warning signs that are already here.
Sources and References
- Centers for Disease Control and Prevention (CDC) — Emergence of Extensively Drug-Resistant Shigellosis, United States, 2011–2023. Morbidity and Mortality Weekly Report (MMWR), April 9, 2025. https://www.cdc.gov/mmwr/volumes/75/wr/mm7513a1.htm
- California Department of Public Health (CDPH) — Rise in Extensively Drug-Resistant Shigella Strains. California Health Alert Network (CAHAN) Advisory. https://www.cdph.ca.gov/Programs/OPA/Pages/CAHAN/Rise-in-Extensively-Drug-Resistant-Shigella-Strains.aspx
- CDC Emerging Infectious Diseases Journal — Genomic Modeling of an Outbreak of Multidrug-Resistant Shigella sonnei, California, USA, 2023–2024. Volume 31, Supplement — May 2025. https://wwwnc.cdc.gov/eid/article/31/13/24-1307_article
- Los Angeles County Department of Public Health — Health Advisory: Increase in Extensively Drug-Resistant Shigella Cases in LA County, June 2025. https://ehs.ucla.edu/news/lac-dph-health-advisory-increase-extensively-drug-resistant-shigella-cases-lac
- Santa Clara County Public Health — Health Advisory: Drug Resistant Shigella Outbreak Associated with Homeless Encampments in San Jose, June 2024. https://publichealthproviders.santaclaracounty.gov/health-advisory-shigella-outbreak-associated-homeless-encampments-san-jose
- CIDRAP (Center for Infectious Disease Research and Policy) — Novel Strain of Extensively Drug-Resistant Shigella Identified in Los Angeles. December 2024. https://www.cidrap.umn.edu/antimicrobial-stewardship/novel-strain-extensively-drug-resistant-shigella-identified-los-angeles
- Patch.com — Drug-Resistant Stomach Bug On The Rise: What To Know In CA. April 2026. https://patch.com/california/across-ca/drug-resistant-stomach-bug-rise-what-know-ca
- Fox News Health — CDC Warns Drug-Resistant Shigella Infections Are Rising Across US. April 2026. https://www.foxnews.com/health/antibiotic-resistant-bacteria-linked-severe-stomach-illness-across-us
- Centers for Disease Control and Prevention (CDC) — Public Health Considerations for Shigellosis Among People Experiencing Homelessness. https://www.cdc.gov/shigella/php/public-health-strategy/index.html
- Santa Clara County Public Health — Update on Drug Resistant Shigella Outbreak Associated with Homeless Encampments in San Jose, June 24, 2024. https://publichealth.santaclaracounty.gov/news/press-statement/update-shigella-outbreak-associated-homeless-encampments-san-jose-june-24-2024
- Spokane Regional Health District — Shigella Advisory for Health Care Providers, January 2025. https://srhd.org/shigella-advisory-for-health-care-providers-jan-23-2025
- CitizenPortal.ai — Communicable Disease Unit Tackles Drug Resistant Shigella and Syphilis Outbreaks Among Homeless Population, Santa Cruz County, March 2025. https://citizenportal.ai/articles/2642711/Santa-Cruz-County/California/Communicable-Disease-Unit-tackles-Shigella-and-syphilis-outbreaks-among-homeless-population
I now use home remedies like turmeric tea and ginger every day. These simple, plant-based solutions help my body heal itself. Nature gives us all we need to stay healthy, without complicated formulas.